CVRX CVRx, Inc. Insider Trading

CVRx Director Mudit K. Jain buys 46,800 shares at $6.36; prior same-ticker buys at this level showed 42.8% and 55.4% 90-day returns

Jain acquired 46,800 shares at $6.36, expanding his holdings by 5.0% to 980,183 shares. This marks his third purchase at CVRx in nine months, following buys on 2025-05-12 and 2025-05-13 that delivered 90-day returns of 55.4% and 42.8% respectively. The current share price of $6.79 sits -54.7% from the 52-week high of $14.98 and down -32.0% over the past 90 days. The company remains unprofitable, reporting a net loss of $12,870,000.00 against quarterly revenue of $14,690,000.00. The pattern of consecutive buys at similar price points after prior accumulations at this level warrants tracking whether this level again attracts support, though the ongoing losses and recent price pressure present material headwinds.

Director Jain bought 600 CVRX shares at $4.64; stock down 67.9% from 52-week high, director's 2 prior CVRX buys both posted +42% 90-day returns.

Director Mudit K. Jain purchased 600 shares of CVRx at $4.64 on 2026-02-18, increasing his holdings to 5,650 shares (+11.9%). The purchase occurs as the stock trades 67.9% below its 52-week high of $15.09 and has declined 44.9% over the past 90 days. Notably, Jain's two prior purchases of CVRX in May 2025 both delivered strong subsequent returns: the May 13 buy posted a 90-day return of +42.8%, and the May 12 buy returned +55.4% over 90 days. His cross-ticker track record shows 2 prior buys with an average 90-day return of +49.1% and a 100% win rate. While CVRx remains unprofitable (net income of $-12.9M on latest quarterly revenue of $14.7M), the director's consistent history of well-timed accumulation at this ticker—particularly during drawdowns—may warrant tracking to see whether this purchase pattern repeats its prior success or if deteriorating fundamentals (company remains loss-making despite 10.4% annual revenue growth) present a different risk profile this time.

Director Kirk G. Nielsen bought 10,966 shares of CVRX at $5.45 on 2025-05-15; part of cluster pattern with 2 other insider buys in past 14 days.

Director Kirk G. Nielsen purchased 10,966 shares at $5.45, bringing his total holdings to 1,910,134 shares. This transaction is part of a cluster pattern: two other insiders also bought within the past 14 days at the same ticker. The stock currently trades at $6.85, down 62.8% from its 52-week high of $18.40 and is in the midst of a steep 90-day decline of -54.3%, though it has recovered +9.6% over the past 30 days. The company is unprofitable, with a net loss of $13,766,000.00 against quarterly revenue of $12,348,000.00, though annual revenue growth stands at +30.5%. Nielsen's three prior purchases at CVRX (on 2025-05-12, 2025-05-13, and 2025-05-14) were all made within the same compressed timeframe, and outcomes are not yet measurable. The synchronized buying activity across multiple insiders amid a significant stock price decline warrants attention to underlying business developments.

Director Nielsen Kirk G. purchased 187,813 shares across 3 transactions (May 12-14) for $977,346.35; cluster buy with 2 other insiders in 14 days.

Director Nielsen Kirk G. completed 3 separate purchases totaling 187,813 shares for $977,346.35 between May 12-14, expanding his holdings by 11.0% to 1,899,168 shares. The blended average price of $5.20 is occurring while the stock is -71.2% from its 52-week high of $18.40 and has declined 19.0% over the prior 30 days. Critically, this purchase activity is part of a cluster pattern: 2 other insiders also bought within the same 14-day window, suggesting coordinated insider confidence despite the company's fundamental challenges (unprofitable with net income of $-13,766,000.00 against revenue of $12,348,000.00 in the latest quarter). The large dollar magnitude ($977.3K) and significant share increase (11.0% of prior holdings) warrant observation of whether this represents conviction in recovery or reflects valuation-driven accumulation at depressed levels following the 63.5% decline over 90 days.

Director Jain Mudit K. bought 1,650 shares at blended average $4.71 (May 12-13); cluster pattern with 2 other insiders buying within 14 days.

Jain Mudit K., a director at CVRx, made 2 separate purchases totaling 1,650 shares for $7,774.95, increasing his holdings from 3,400 to 5,050 shares (+48.5% net change). The blended average purchase price of $4.71 is below the current price of $5.44 but well below the 52-week high of $18.40; the stock is currently -70.4% from that high and -63.0% over 90 days. Most notably, this purchase is part of a cluster pattern: 2 other insiders also bought within the past 14 days. The company is currently unprofitable (net income $-13.8M in the latest quarter) despite strong revenue growth of +30.5% year-over-year, suggesting insiders may be responding to depressed valuation amid operational challenges. The cluster buying pattern across multiple insiders warrants attention as a potential indicator of internal assessment of the stock's recovery potential.

CVRX CEO Kevin Hykes bought 5,000 shares at $4.84 amid -74.2% decline from 52-week high; 2 other insiders bought within 14 days.

CEO Kevin Hykes purchased 5,000 shares at $4.84 on 2025-05-12, increasing his holdings from 128,000 to 133,000 shares. The stock trades 74.2% below its 52-week high of $18.40 and has declined 67.4% over the past 90 days. His single prior CVRX purchase (2024-08-05) achieved +60.3% returns over 90 days, demonstrating well-timed entry discipline at this ticker. Notably, 2 other insiders also purchased CVRX shares within the past 14 days, forming a cluster buy pattern. However, the company remains unprofitable ($-13.8M net income) despite 30.5% annual revenue growth ($12.3M quarterly revenue), creating a risk backdrop where insider accumulation at depressed levels requires scrutiny of whether price recovery can be sustained.

Director Slattery buys 3,000 shares of CVRX at $8.10; stock down 75.7% from 52-week high, unprofitable firm with 74.9% revenue growth.

Director Joseph P. Slattery purchased 3,000 shares at $8.10 on August 15, 2024, increasing his holdings to 30,645 shares (+10.9% increase). The purchase occurs within a context of significant stock depreciation: the current price of $8.01 is 75.7% below the 52-week high of $33.01, and the stock has fallen 19.2% over the past 30 days. CVRx remains unprofitable with net income of $-14.0M against quarterly revenue of $11.8M, though the company posted 74.9% annual revenue growth. This is Slattery's second purchase of CVRX in a week (following a buy on August 8), but neither transaction has yet completed a 90-day measurement period. His cross-ticker track record shows 3 prior buys with a 100% win rate and average 90-day return of +92.7%, but this historical outperformance offers no direct evidence of timing accuracy at this specific ticker.

Director Joseph Slattery buys 3,000 CVRX shares at $8.24; holdings now 27.6K shares. Stock -74.3% from 52-week high.

Director Joseph Slattery purchased 3,000 shares of CVRx, Inc. (CVRX) at $8.24 on 2024-08-08, increasing his holdings by 12.2% to 27.6K shares post-transaction. This buy occurs while the stock trades at $8.49, which is -74.3% from its 52-week high of $33.01 and down -27.0% over the past 30 days. Notably, Slattery executed a similar buy just two days prior on 2024-08-06, suggesting sequential accumulation at depressed prices. The company is unprofitable (net income $-14.0M in the latest quarter) though it is growing revenue rapidly (+74.9% year-over-year to $11.8M quarterly), indicating early-stage commercial trajectory. The sequential buys within a 48-hour window during a pronounced downtrend warrant attention to whether this reflects genuine conviction in a recovery or opportunistic purchasing amid volatility.

Director Slattery buys 2,500 CVRX shares at $9.09; stock down 72.6% from 52-week high after -26.8% in 30 days.

Joseph P. Slattery, a Director of CVRx, Inc., purchased 2,500 shares at $9.09 on 2024-08-06, expanding his holdings from 22,145 to 24,645 shares—an increase of 11.3%. The purchase occurs following sharp recent price weakness, with the stock trading at $9.05 (current) versus its 52-week high of $33.01, representing a 72.6% decline from that peak. Over the preceding 30 days alone, the stock fell 26.8%. Slattery's cross-ticker insider track record shows favorable execution: 1 prior open-market buy with an average 90-day return of +92.7% and a 100% win rate, suggesting his historical buys have been followed by price recovery. However, CVRx remains unprofitable (latest full-year net income was negative) despite strong top-line growth of 74.9% year-over-year; the company generated revenue of $11,800,000.00 in its most recent quarter against a net loss of $14,029,000.00. The purchase signals continued commitment to the company at depressed levels, though investors should note the uncertain profitability trajectory and volatility profile.

CVRX CEO Hykes purchases 30,000 shares at $8.36 as stock trades -74.4% from 52-week high

Kevin Hykes, President & CEO of CVRx, initiated a 30,000-share position at $8.36, representing his first purchase in this stock and a total value of $250,767.00. This transaction occurs in the context of significant price deterioration: the stock is -74.4% from its 52-week high of $33.01 and has declined -31.6% over the past 30 days, though it shows a +4.4% gain over 90 days. The company is unprofitable with a $-14.0M net income in the latest quarter against $11.8M revenue, yet has demonstrated strong annual revenue growth of +74.9%. The entry represents a newly-established insider position at severely compressed valuation relative to recent trading history, though the company remains loss-making. Investors should monitor whether this purchase signals management's confidence in a turnaround or reflects routine portfolio positioning in a capital-efficient stage company.